Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rebalancing metal dyshomeostasis for Alzheimer’s disease therapy
Guan–Jun Yang, Hao Liu, Dik‐Lung Ma, et al.
JBIC Journal of Biological Inorganic Chemistry (2019) Vol. 24, Iss. 8, pp. 1159-1170
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer’s Disease, Parkinson’s Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis
Phuong H. Nguyen, Ayyalusamy Ramamoorthy, Bikash R. Sahoo, et al.
Chemical Reviews (2021) Vol. 121, Iss. 4, pp. 2545-2647
Open Access | Times Cited: 538
Copper Metabolism and Cuproptosis: Molecular Mechanisms and Therapeutic Perspectives in Neurodegenerative Diseases
Xiao-xia Ban, Hao Wan, Xin-xing Wan, et al.
Current Medical Science (2024) Vol. 44, Iss. 1, pp. 28-50
Open Access | Times Cited: 27
Polyphenols as Potential Metal Chelation Compounds Against Alzheimer’s Disease
Johant Lakey‐Beitia, Andrea Burillo, Giovanni La Penna, et al.
Journal of Alzheimer s Disease (2020) Vol. 82, Iss. s1, pp. S335-S357
Open Access | Times Cited: 114
Role of metals in Alzheimer’s disease
Nikita Das, James Raymick, Sumit Sarkar
Metabolic Brain Disease (2021) Vol. 36, Iss. 7, pp. 1627-1639
Closed Access | Times Cited: 90
Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer’s Disease
Vinay Chaudhari, Siddhi Bagwe‐Parab, Harpal S. Buttar, et al.
Neurotoxicity Research (2023) Vol. 41, Iss. 3, pp. 270-287
Closed Access | Times Cited: 30
Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer’s Disease
Raghuraj Singh, Archna Panghal, Krishna Jadhav, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 12, pp. 10916-10940
Closed Access | Times Cited: 10
Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer’s Disease
Jiyeon Han, Cheng‐Feng Du, Mi Hee Lim
Accounts of Chemical Research (2021) Vol. 54, Iss. 20, pp. 3930-3940
Closed Access | Times Cited: 52
Neuropeptides: Roles and Activities as Metal Chelators in Neurodegenerative Diseases
Shira Ben-Shushan, Yifat Miller
The Journal of Physical Chemistry B (2021) Vol. 125, Iss. 11, pp. 2796-2811
Open Access | Times Cited: 46
Biological Potential, Gastrointestinal Digestion, Absorption, and Bioavailability of Algae-Derived Compounds with Neuroprotective Activity: A Comprehensive Review
Bruna Cristina Cardoso Martins, Mónica Vieira, Cristina Delerue‐Matos, et al.
Marine Drugs (2022) Vol. 20, Iss. 6, pp. 362-362
Open Access | Times Cited: 29
Development of the “hidden” multi-target-directed ligands by AChE/BuChE for the treatment of Alzheimer's disease
Rui Chen, Xinjuan Li, Hongsong Chen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 251, pp. 115253-115253
Closed Access | Times Cited: 19
Targeting Biometals in Alzheimer’s Disease with Metal Chelating Agents Including Coumarin Derivatives
Adrián Gucký, Slávka Hamuľaková
CNS Drugs (2024) Vol. 38, Iss. 7, pp. 507-532
Open Access | Times Cited: 6
Targeting PGAM1 in cancer: An emerging therapeutic opportunity
Guan–Jun Yang, Tao Fan, Hai‐Jing Zhong, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114798-114798
Closed Access | Times Cited: 27
Second Sphere Interactions in Amyloidogenic Diseases
Madhuparna Roy, Arnab Kumar Nath, Ishita Pal, et al.
Chemical Reviews (2022) Vol. 122, Iss. 14, pp. 12132-12206
Closed Access | Times Cited: 19
Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer’s Disease Agents
Viviana Poliseno, Sı́lvia Chaves, Leonardo Brunetti, et al.
Biomolecules (2021) Vol. 11, Iss. 1, pp. 111-111
Open Access | Times Cited: 25
Carrier-free Chinese herbal small molecules self-assembly with 3D-porous crystal framework as a synergistic anti-AD agent
Rui Shen, Yuhong Chen, Xiangyu Li, et al.
International Journal of Pharmaceutics (2022) Vol. 630, pp. 122458-122458
Closed Access | Times Cited: 15
Peroxidase activity of heme bound amyloid β peptides associated with Alzheimer's disease
Madhuparna Roy, Ishita Pal, Arnab Kumar Nath, et al.
Chemical Communications (2020) Vol. 56, Iss. 33, pp. 4505-4518
Closed Access | Times Cited: 21
Unraveling the role of ubiquitin-conjugating enzyme 5 (UBC5) in disease pathogenesis: A comprehensive review
Jinjin Shi, Ru-Yi Chen, Yanjun Liu, et al.
Cellular Signalling (2024) Vol. 124, pp. 111376-111376
Closed Access | Times Cited: 2
Nasal Delivery of D-Penicillamine Hydrogel Upregulates a Disintegrin and Metalloprotease 10 Expression via Melatonin Receptor 1 in Alzheimer’s Disease Models
Manli Zhong, Hejia Kou, Pu Zhao, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 13
Metal ions and degenerative diseases
Liliana Quintanar, Mi Hee Lim
JBIC Journal of Biological Inorganic Chemistry (2019) Vol. 24, Iss. 8, pp. 1137-1139
Open Access | Times Cited: 14
The Metallome as a Link Between the “Omes” in Autism Spectrum Disorders
Janelle E. Stanton, Sigita Malijauskaite, Kieran McGourty, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 11
Multifunctional Small Molecules as Potential Anti-Alzheimer’s Disease Agents
Beatrice Bargagna, Lidia Ciccone, Susanna Nencetti, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 6015-6015
Open Access | Times Cited: 11
Multifunctional fluorescence sensor as a potential theranostic agent against Alzheimer's disease
Xiaodi Kou, Xingying Li, Chengting Hu, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2021) Vol. 267, pp. 120587-120587
Closed Access | Times Cited: 11
The Metallic Mysteries: Deciphering Their Contribution to Alzheimer’s Pathogenesis
SA Kalwaghe, SS Sadar, Pradip Porwal, et al.
International Journal of Pharmaceutical Sciences and Drug Research (2024), pp. 496-505
Open Access | Times Cited: 1
Urinary Metal Levels, Cognitive Test Performance, and Dementia in the Multi-Ethnic Study of Atherosclerosis
Arce Domingo-Relloso, Katlyn E. McGraw, Susan R. Heckbert, et al.
JAMA Network Open (2024) Vol. 7, Iss. 12, pp. e2448286-e2448286
Closed Access | Times Cited: 1
Synthesis, molecular docking and spectroscopic studies of pyridoxine carbamates as metal chelator
Tiyas Pal, Pooja M. Patil, Abha Sharma
Journal of Molecular Structure (2020) Vol. 1223, pp. 128837-128837
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top